Delivery Order SPE2DB20D1100-SPE2DB25FE5D2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of lisdexamfetamine 40 mg capsules (100-count units) with a ceiling value of $1,886.66. This firm fixed-price delivery order, with an ultimate completion date of May 21, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $2,853.60. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents performance at the contractor's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) with a contract ceiling value of $2,727.39. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) with a ceiling value of $20,729.23. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) valued at $5,911.41. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $2,136.69. The award, effective September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100 count) valued at $1,426.80. The contract is a firm fixed-price delivery order with a completion date of August 8, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This order will be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100-count units) with a ceiling value of $1,831.04. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026. The product will...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine capsules 30mg, with a ceiling value of $4,474.11. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is due for completion by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5D2Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $1,070.16. This firm fixed price delivery order represents a competitive award with no set-aside designation and is expected to be completed by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal healthcare systems. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. AmerisourceBergen leverages this IDC vehicle to supply a wide range of pharmaceutical products, medical devices, and healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements through open competitive procurement, positioning it as a critical vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/8/25 |